icon-folder.gif   Conference Reports for NATAP  
 
  EASL 47th Annual Meeting
April 18th - 22nd 2012
Barcelona, Spain
Back grey_arrow_rt.gif
 
 
 
The Effect of Hepatic Impairment on the Safety, Pharmacokinetics, and Antiviral Activity of GS-7977 in Hepatitis C Infected Subjects Treated for Seven Days
 
 
  Reported by Jules Levin
EASL 2012 Barcelona Spain Apr 18-22
 
E. Lawitz1, M. Rodriguez-Torres2, M. Cornpropst3, J. Denning3, D. Clemons3, L. McNair3, L. Fang4, M. Berrey5, W. Symonds3 1Alamo Medical Research, San Antonio, TX, USA, 2Fundacion de Investigacion, San Juan, USA, 3Gilead Sciences, Inc., Durham, NC, USA, 4Pharstat, Inc., Research Triangle Park, NC, USA,5Pharmasset, Inc., Durham, NC, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL2.gif

table2.gif

EASL5.gif

EASL6.gif